|
| |
Now in its 3rd year, OBN’s BioTrinity 2009 conference unites the UK’s life science industry. Come and experience what will be the best biotech partnering and investment conference in the country through this two-day programme. Join top-notch industry executives, including the South East region’s most innovative biotech entrepreneurs, major pharmaceutical companies, life science research leaders, policy makers and internationally prominent investors at the biotechnology event of the year: BioTrinity 2009. New for 2009:
Facts from 2008:
|
Early Confirmations: Merck Brisol Myers-Squibb Shire Pharma Teva Pharma EUSA Pharma Takeda Research Investment Inc Novo Ventures Innovator Capital MP Healthcare Venture Management Oxford Capital Partners Domainex Piramed Pharma PharmaTelevision
|
WHO SHOULD ATTEND?Biotech & MedTech Executives
Mid & Large Pharma Executives
Investors
| |
Registration FeesRegister now online at www.biotrinity.com to take advantage of the Super Early Bird offer
| |
|
Super Early Registration Fee (until Oct 1, 2008) Early Bird Registration Fee (until Dec 15, 2008) Special Registration Fee (until Feb 14, 2009) Registration Fee (until April 1, 2009) On-site Registration Fee |
£449 + VAT £499 + VAT £549 + VAT £599 + VAT £650 + VAT |
|
| |